Osteoclasts are required for bone resorption. A new study in mice indicates that osteoclast differentiation is stabilized by DNA methylation at Irf8 (encoding interferon regulatory factor 8) mediated by DNA methyltransferase 3a (Dnmt3a), which suppresses Irf8 gene expression. The activity of Dnmt3 in osteoclasts requires elevated oxidative metabolism.
References
Nakashima, T., Hayashi, M. & Takayanagi, H. Trends Endocrinol. Metab. 23, 582–590 (2012).
Zhao, B. et al. Nat. Med. 15, 1066–1071 (2009).
Zhao, B. & Ivashkiv, L.B. Arthritis Res. Ther. 13, 234 (2011).
Kaelin, W.G. Jr. & McKnight, S.L. Cell 153, 56–69 (2013).
Asagiri, M. et al. J. Exp. Med. 202, 1261–1269 (2005).
Yasui, T. et al. J. Bone Miner. Res. 26, 2665–2671 (2011).
Nishikawa, K. et al. Nat. Med. 21, 281–287 (2015).
Zhao, B., Grimes, S.N., Li, S., Hu, X. & Ivashkiv, L.B. J. Exp. Med. 209, 319–334 (2012).
Ishii, K.A. et al. Nat. Med. 15, 259–266 (2009).
Lamoureux, F. et al. Nat. Commun. 5, 3511 (2014).
Park-Min, K.H. et al. Nat. Commun. 5, 5418 (2014).
Gosselin, D. et al. Cell 159, 1327–1340 (2014).
Lavin, Y. et al. Cell 159, 1312–1326 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ivashkiv, L. Metabolic-epigenetic coupling in osteoclast differentiation. Nat Med 21, 212–213 (2015). https://doi.org/10.1038/nm.3815
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3815
- Springer Nature America, Inc.
This article is cited by
-
ELMO1 signaling is a promoter of osteoclast function and bone loss
Nature Communications (2021)
-
DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis
Epigenetics & Chromatin (2019)
-
Visual Osteoclast Fusion via A Fluorescence Method
Scientific Reports (2018)